Quick Takeaways
- TCG Crossover GP I, LLC filed SCHEDULE 13G/A for Cogent Biosciences, Inc. Common Stock, par value $0.001 per share (COGT).
- Disclosed ownership: 4.8%.
- Date of event: 30 Sep 2025.
TCG Crossover GP I, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Cogent Biosciences, Inc. Common Stock, par value $0.001 per share (COGT)
- Filing Manager
- TCG Crossover GP I, LLC
- Reporting Manager
- TCG Crossover GP I, LLC
- Symbol
- COGT
- Shares outstanding
- 141,628,375 shares
- Disclosed Ownership
- 6,798,162 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:25:35 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"TCG Crossover GP I, LLC disclosed 4.8% ownership in Cogent Biosciences, Inc. Common Stock, par value $0.001 per share (COGT) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 16:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP I, LLC | 4.8% | 6,798,162 | 0 | 6,798,162 | /s/ Craig Skaling | Authorized Signatory | |
| TCG Crossover Fund I, L.P. | 4.8% | 6,798,162 | 0 | 6,798,162 | /s/ Craig Skaling | Authorized Signatory | |
| Chen Yu | 4.8% | 6,798,162 | 0 | 6,798,162 | /s/ Craig Skaling | By POA as Attorney-in-Fact |